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po the Editor: In over 27,000 patients treated for ST-segment
levation myocardial infarction (STEMI) with primary percutane-
us coronary intervention (PCI) in the U.S., the average time from
ymptom onset to PCI (ischemic time) was 5.5 h (1), which is well
eyond the 2-h goal for optimal salvage (2). Brodie et al. (3)
howed that ischemic times 2 h decreased mortality compared
ith longer ischemic times (4.3% vs. 9%, p  0.04). The
ATCAR (Prehospital Administration of Thrombolytic Therapy
ith Urgent Culprit Artery Revascularization) pilot trial evaluated
he feasibility that reduced-dose pre-hospital fibrinolysis coupled
ith urgent PCI could reduce ischemic time in STEMI patients.
Four STEMI patient groups were evaluated: Group A, full-
ose, pre-hospital fibrinolysis followed by treatment in the coro-
ary care unit; Group B, one-half-dose pre-hospital reteplase
ollowed by urgent PCI; Group C, patients who were fibrinolytic
neligible, and Group D, patients not transported by participating
mergency medical systems (EMS) units. Groups C and D were
reated with primary PCI at the STEMI center.
Reperfusion: 70% ST-segment resolution on 12-lead electro-
ardiogram with reduction in chest pain or Thrombolysis In
yocardial Infarction (TIMI) flow grade 2 to 3 infarct-related
rtery (IRA) flow on initial or post-PCI angiogram.
Major bleeding (GUSTO [Global Use of Strategies to Open
ccluded Arteries] definition): Bleeding resulting in substantial
emodynamic instability requiring intervention.
Differences among the treatment groups were assessed by the
isher exact test for categorical variables and by analysis of variance
or continuous variables with normal distribution. Otherwise,
nalysis of variance on ranks was used. Pair-wise multiple com-
arisons were done using the Dunn method. A 2-tailed p-value
0.05 was considered statistically significant.
Informed consent was obtained from 73 patients enrolled from
eptember 2003 to January 2006. Of 60 STEMI patients identi-
ed before entering the hospital, 46 were fibrinolytic eligible and
ere treated in the ambulance with 10 units reteplase, intravenous
eparin and oral aspirin, and randomized to either a second
0-unit dose of reteplase (Group A, n  22) or urgent catheter-
zation with PCI (Group B, n  24). Fibrinolytic-ineligible
atients and patients brought in by nonparticipating EMS systems
reated with primary PCI alone were prospectively analyzed for
omparison (Group CD-non-transfer [NT], n  27). Four
atients were excluded from analysis in Groups A and B because of anadvertent treatment delays or false-positive electrocardiogram
esults.
Group B experienced shorter ischemic times than Group A,
165  54 min vs. 270  109 min, p  0.05) and Group
D-NT (221  143 min, trend, p  0.08) (Table 1). The time
rom contact to reperfusion was 114  33 min in Group B,
ompared with 168  59 min in Group A and 148  94 min in
roup CD-NT (p  0.014, B vs. A and p  0.044 for all 3
roups).
Eighty-two percent of Group B patients had TIMI flow grade
or 3 in the IRA on initial angiography, compared with 37% of
rimary PCI patients (p  0.002) (Table 1). The incidence of
ngiographic perfusion score  10 (4) in Group B patients was
7%, compared with 22% in Group CD-NT (p 0.003) (Table
, Fig. 1).
No patient experienced an intracranial hemorrhage, and strokes
ere rare. One patient in Group B experienced a major bleed that
ccurred 4 days after admission and was not secondary to fibrino-
ytic therapy (Table 1).
Initial IRA TIMI flow grades of 2 to 3 are correlated with
mproved survival (5) and were observed in 82% of Group B
atients, compared with only 37% in Group CD-NT
p  0.002). Full reperfusion (TIMI angiographic perfusion score
10) is also correlated with survival (4), and was found in 67% of
roup B compared with 22% of Group CD-NT (p  0.003)
atients.
LeMay et al. (6) reported that full-dose teneteplase-coupled
ngioplasty was not associated with increased bleeding risk. Bleed-
ng risk was not increased with partial-fibrinolysis-coupled PCI in
ur patients.
Sixty-eight percent of patients crossed over from Group A to
escue PCI for persistent symptoms, ST-segment elevation, or
emodynamic instability. Less than 50% of these had TIMI
ow grade 2 or 3 IRA compared with 80% of the patients in
roup B. This suggests that routine PCI immediately after
re-hospital fibrinolysis, irrespective of clinical setting, should
e the standard of care.
The majority of ASSENT (Assessment of the Safety and
fficacy of a New Treatment Strategy with Percutaneous Coronary
nterventions)-4 PCI patients had significant delays from onset of
ain to treatment; those who received fibrinolytic agents in the
mbulance had more favorable outcomes than those treated with
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October 16, 2007:1612–6rimary PCI alone (7). The total stroke rate of 1.8% in the
brinolytic arm of the ASSENT-4 study was similar to the stroke
ate reported in the ASSENT-3 study with the same fibrinolytic
gent (8).
This was a relatively small feasibility study that was not powered
o detect a difference in major outcomes (mortality, stroke,
einfarction, and major bleeding) among the groups. Groups A
nd B were randomized; however, Group CD-NT was an
bservational arm, which limits interpretation of the findings.
The strategy of diagnosing STEMI in chest pain patients and
dministering reduced-dose fibrinolytic agents, heparin, aspirin,
nd clopidogrel in the field with simultaneous notification of the
omparison of Timing of Events in Each Group
Table 1 Comparison of Timing of Events in Each Group
A
Number of patients 20
Onset to contact (min) 102 98 (n 20)*
Onset to door (min) 166 118 (n 20)
Onset to lytic (min) 144 108 (n 20)
Ischemic time (min) 270 109 (n 20)*
Contact to reperfusion (min) 168 59 (n 20)
Onset to balloon (min) N/A
Door to balloon (min) N/A
Revascularization within 48 h of admittance 85%
TIMI flow grade 2 to 3 on initial angiograph 60% (n 20)
TIMI perfusion score 10 53% (n 19)
70% ST-segment resolution by CCU 70% (n 20)
GUSTO major bleeding# 0% (n 20)
ICH 0% (n 20)
Any stroke 0% (n 20)
Reinfarction 0% (n 19)
30-day mortality 0% (n 19)
p 0.05 Group A versus Group B. †p 0.08 Group B versus Group CDNT. ‡p 0.014 Group
p  0.002 Group B versus Group CDNT. #Circulation 1997;95:2508–16.
ANOVA  analysis of variance among 3 groups; CCU  coronary care unit; GUSTO  Global Use
or analysis; N/A  not applicable; NS  not significant; TIMI  Thrombolysis In Myocardial Infarc
Figure 1 Percentage of Patients WithAngiographic Perfusion Score >10
Percentage of patients with infarct-related artery angiographic Thrombolysis In
Myocardial Infarction perfusion score 10 on final angiograph in Groups A, B,
and CD-NT.CI team significantly reduced ischemic time, improved the
uality of early myocardial reperfusion, and was not associated with
xcessive bleeding risks compared with full-dose pre-hospital
brinolysis alone or primary PCI in an urban setting. Patients with
rief pre-hospital cardiac arrest, those with shock, and elderly
atients were not excluded, suggesting that this strategy might be
roadly applicable. Our data and those of Thiele et al. (9) suggest
hat reduced-dose pre-hospital fibrinolysis allows safe transport of
TEMI patients to PCI centers for urgent culprit artery PCI, and
ay be a superior approach compared with transporting patients to
he closest non-PCI hospital for fibrinolytic therapy. Whether this
trategy is superior to primary PCI remains to be determined.
urther evaluation of the strategy of pre-hospital fibrinolytic
cceleration of STEMI treatment coupled with urgent PCI
FAST-PCI) in a large multicenter randomized trial compared
ith primary PCI seems warranted.
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Groups
ANOVAB CDNT
22 27
50 44 (n 22) 58 55 (n 23) p 0.03
107 46 (n 22) 115 90 (n 25) NS
91 45 (n 22) NA N/A
165 54 (n 22)† 221 143 (n 24) p 0.002
114 33 (n 22)‡ 148 94 (n 23) p 0.044
180 53 (n 18) 225 134 (n 22) N/A
74 30 (n 18)§ 136 88 (n 23) N/A
82% 85% NS
82% (n 22) 37% (n 27) p 0.007
67% (n 18)¶ 22% (n 23) p 0.013
68% (n 22) 63% (n 24) NS
4.5% (n 22) 0% (n 27) NS
0% (n 22) 0% (n 27) NS
0% (n 22) 3.7% (n 27) NS
0% (n 21) 0% (n 26) NS
4.8% (n 21) 3.8% (n 26) NS
s Group B. §p0.05 Group B versus Group CDNT. p 0.003 Group B versus Group CDNT.
tegies to Open Occluded Arteries; ICH  intracranial hemorrhage; n  total data points availableA versudoi:10.1016/j.jacc.2007.07.020
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iagnostic and Prognostic Value
he paper by Yu et al. (1) in the Journal summarized the
pplications of tissue Doppler imaging (TDI). However, we
onsider additional clinical applications to be very important.
e have used TDI routinely for after-transplant monitoring since
998. Our studies proved TDI’s reliability for early detection of
cute rejection and transplant coronary artery disease (TxCAD)
nd showed that serial TDI can spare patients unnecessary and
istressing routine invasive examinations (2,3). Tissue Doppler
maging also appeared reliable for prognostic estimations after
eart transplantation and for the evaluation of rejection severity
nd guidance of antirejection therapy (2,3). Recently we showed
hat TDI can also be helpful in evaluations of myocardial recovery
uring mechanical unloading after ventricular assist device (VAD)
mplantation (4).
We do not agree with Yu et al. (1) that myocardial deformation
maging is not ready for routine clinical use. Recently, Perk et al.
5) emphasized the clinical reliability of the method. We use
-dimensional strain imaging routinely for patients’ evaluation
efore and after coronary surgery and also for noninvasive moni-
oring of allograft function after heart transplantation. Addition-
lly, 2-dimensional strain imaging is our method of choice for
atient selection for surgical ventricular restoration (SVR) after
evere myocardial infarction. We found that the systolic dyssyn-
hrony indexes and global strain rate are reliable for evaluation of
yocardial functional changes during postoperative reverse re-
odeling processes after SVR. The 2-dimensional strain method
lso improved our ability to evaluate cardiac recovery after VADrom their assist devices. In heart-transplanted patients, we found
hat systolic strain dyssynchrony and dyssynergy indexes are more
seful than pulsed-wave TDI parameters for differentiation be-
ween angiographic TxCAD with and without proximal focal
tenoses.
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